Skip to main content
. 2019 Mar 20;3(1):bjgpopen18X101634. doi: 10.3399/bjgpopen18X101634

Table 2. Primary and secondary outcomes.

Mean outcome
(95% CI)a
Crude intervention-
control difference
(95% CI);
P valueb
Adjusted intervention-
control difference
(95% CI);
P valueb
Intervention
(clusters = 15)
Control
(clusters = 15)
Primary outcomes
BODE index
score changec
-1.67
(-2.18 to -1.16)
-0.66
(-1.09 to -0.22)
-1.01
(-1.65 to -0.37);
0.003
-0.96
(-1.49 to -0.44);
0.001
COPD controld 66.88%
(54.99 to 78.77)
38.20%
(22.35 to 54.06)
28.68%
(9.68 to 47.67);
0.005
29.03%
(12.41 to 45.64);
0.001
Secondary outcome
Quit rate
among smokerse
53.90%
(34.98 to 72.82)
17.52%
(7.36 to 27.69)
36.38%
(15.66 to 57.10);
0.002
31.98%
(15.42 to 48.54);
0.001
Follow-up
adherencef
65.54%
(52.64 to 78.44)
25.17%
(14.86 to 35.47)
40.38%
(24.57 to 56.18);
<0.001
40.40%
(24.15 to 56.67);
<0.001

aArm-specific mean outcomes and their 95% confidence intervals are calculated from cluster-level mean and/or proportion summary values of outcomes. bAll intervention minus control differences (that is, intervention effect estimates) are based on crude and/or covariate-adjusted analysis of cluster-level mean and/or proportion summary values of outcomes. cBODE index score change calculated as outcome at 6-month follow-up minus outcome at baseline. dCOPD control defined as BODE index ≤ 2 at 6-month follow-up. eQuit rate among smokers calculated as smokers who had quit smoking at 6-month follow-up. fFollow-up adherence defined as attending ≥4 follow-up visits. All analyses use only complete cases.

BODE = Body mass index, airway Obstruction, Dyspnoea, Exercise capacity. CI = confidence intervals. COPD = chronic obstructive pulmonary disease.